COMMUNIQUÉS West-GlobeNewswire

scPharmaceuticals to Announce Second Quarter 2025 Financial Results After the Market Close on August 7, 2025
31/07/2025
Management to host conference call and webcast, after-market on August 7, 2025, at 4:30 p.m. ET BURLINGTON, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company [...]
Ascendis Pharma to Report Second Quarter 2025 Financial Results and Provide Business Update on August 7, 2025
31/07/2025
COPENHAGEN, Denmark, July 31, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will report second quarter 2025 financial results and provide a business update on Thursday, August 7, 2025, [...]
Solésence Reports Second Quarter 2025 Financial Results
31/07/2025
Strong commercial execution drove revenue growth of 56% to $20.4 million ROMEOVILLE, Ill., July 31, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across [...]
Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux
31/07/2025
Daix (France), New York (New York, United States), July 31, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“ Inventiva ” or the “ Company ”), a clinical-stage biopharmaceutical company focused on the development of [...]
Bilan semestriel du contrat de liquidité de la société Inventiva conclu avec Kepler Cheuvreux
31/07/2025
Daix (France), New York (New York, Etats-Unis), le 31 juillet 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (la "Société"), société biopharmaceutique spécialisée dans le développement clinique de petites molécules [...]
Nephros Schedules Second Quarter 2025 Financial Results Conference Call
31/07/2025
SOUTH ORANGE, N.J., July 31, 2025 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will [...]
J-Star Holding Announces Closing of $5.0 Million Initial Public Offering
31/07/2025
TAICHUNG CITY, Taiwan, July 31, 2025 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd. (“J-Star” or the “Company”), a leading provider of innovative carbon fiber and composite solutions across a wide range of applications [...]
SeaStar Medical Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
31/07/2025
DENVER, July 31, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and [...]
PolTREG and U.S. Subsidiary Immuthera Secure Positive FDA Opinion, Paving the Way for a Registrational Pre-Symptomatic Type 1 Diabetes Trial
31/07/2025
PolTREG and U.S. Subsidiary Immuthera Secure Positive FDA Opinion, Paving the Way for a Registrational Pre-Symptomatic Type 1 Diabetes Trial FDA agreed that PolTREG’s clinical data in Stage 3 Type 1 Diabetes (T1D) [...]
GRI Bio CEO, Marc Hertz, Participates in Virtual Investor “What This Means” Segment
31/07/2025
Access the “What This Means” segment here LA JOLLA, CA, July 31, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural [...]
SAFE - Chiffre d’affaires du premier semestre 2025 : 2,5 M€
31/07/2025
Chiffre d’affaires du premier semestre 2025 : 2,5 M€ En K€ S1 2025* S1 2024 Variation en % Chiffre d'affaires 2 557 2 587 -1,2% Safe Orthopaedics 1 457 1 303 11,8% Safe Medical 1 100 1 284 -14,3% * Chiffres 2025 non [...]
Availability of 2025 Half-Year Financial Report
31/07/2025
Press Release Paris – July 31, 2025 – EUROAPI posted today its 2025 condensed Half-Year Consolidated Financial Statements for the six months ended June 30, 2025. This document is available for consultation and [...]
Mise à disposition du Rapport financier semestriel 2025
31/07/2025
Communiqué de presse Paris – Le 31 juillet 2025 – EUROAPI a mis en ligne ce jour ses Etats Financiers semestriels consolidés condensés 2025 pour la période close le 30 juin 2025. Ce document est accessible et [...]
Press release: Online availability of Sanofi’s half-year financial report for 2025
31/07/2025
Online availability of Sanofi’s half-year financial report for 2025 Paris, July 31, 2025 . Sanofi announces that its half-year financial report for the period ending June 30, 2025 is now available and has been filed [...]
Communiqué de presse : Mise en ligne du rapport financier semestriel 2025 de Sanofi
31/07/2025
Mise en ligne du rapport financier semestriel 2025 de Sanofi Paris, le 31 juillet 2025 . Sanofi annonce aujourd’hui avoir mis à la disposition du public et déposé auprès de l’Autorité des marchés financiers (AMF) son [...]
NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update
31/07/2025
EDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and [...]
Ipsen S.A. publishes its 2025 Half-Year Report (half-year ended 30 June 2025)
31/07/2025
Ipsen S.A. publishes its 2025 Half-Year Report (half-year ended 30 June 2025) Attachment 2025 Half-year Financial Report_Ipsen SA
Ipsen S.A. publie son Rapport financier semestriel 2025 (semestre clos le 30 juin 2025)
31/07/2025
Ipsen S.A. publie son Rapport financier semestriel 2025 (semestre clos le 30 juin 2025) Pièce jointe 2025 Rapport semestriel_Ipsen SA
Press release: Use of alfapump® to control ascites enabling elective umbilical hernia repair published in Hernia
31/07/2025
Use of alfapump® to control ascites enabling elective umbilical hernia repair published in Hernia Untreated umbilical hernias occur in 20% of patients with ascites due to liver cirrhosis. Without treatment, there is a [...]

Pages